IGM Biosciences Inc reports results for the quarter ended in June - Earnings Summary

IGM Biosciences

09/08/2021 22:20

* IGM Biosciences Inc  IGMS.OQ  reported a quarterly adjusted
loss of $1.16​​ per share for the quarter ended in June. The
mean expectation of eight analysts for the quarter was for a
loss of $1.17 per share.
* Reported revenue was zero​;  analysts expected zero. 
* IGM Biosciences Inc's reported EPS for the quarter was a loss
of $1.16​.
* The mean earnings estimate of analysts had fallen by
about 2.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* IGM Biosciences Inc shares had fallen by 6.6% this quarter and
lost 12.0% so far this year.
* The company reported a quarterly loss of $38.71 million.
* Wall Street's median 12-month price target for IGM Biosciences
Inc is $101.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 9 at 09:19 p.m.  ​All
figures in US dollars unless otherwise stated